Short Synthesis of Molnupiravir (EIDD-2801) via a Thionated Uridine Intermediate.
Ontology highlight
ABSTRACT: Molnupiravir (MK-4482, EIDD-2801) is an experimental drug that has been demonstrated to be effective for the treatment of COVID-19 in human clinical trials. Herein, we report a concise synthesis of the drug via a novel thionated derivative that relies on one-pot methodologies, thus decreasing the number of purification steps required. This route provides the drug in an overall 62% yield and >99% purity and uses cheap and readily available bulk chemicals, thereby providing an affordable synthesis of the drug for cheaper and wider global accessibility.
SUBMITTER: Dey R
PROVIDER: S-EPMC8552467 | biostudies-literature | 2021 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA